ACADIAN ASSET MANAGEMENT LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 100 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 2.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$2,000
-50.0%
166
-52.6%
0.00%
Q4 2016$4,0000.0%3500.0%0.00%
Q3 2016$4,0000.0%3500.0%0.00%
Q2 2016$4,000
-33.3%
3500.0%0.00%
Q1 2016$6,000
-40.0%
3500.0%0.00%
Q4 2015$10,000
+11.1%
350
+5.4%
0.00%
Q3 2015$9,000
-98.8%
332
-98.5%
0.00%
-100.0%
Q2 2015$774,000
+6936.4%
21,561
+8098.1%
0.00%
Q1 2014$11,000
-98.4%
263
-98.5%
0.00%
-100.0%
Q4 2013$670,000
+106.8%
17,345
+87.1%
0.00%
+100.0%
Q3 2013$324,0009,2710.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2014
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders